CASE Op-Ed in The Washington Times: SEC Climate Rule Will Raise the Price of Everything
Green energy has long suffered from a lack of consistency, leaving its customers powerless when the wind isn’t blowing...
CASE Op-Ed – Issues & Insights: Biden Methane Rule Chokes On Climate Change Fallacies
December 20, 2021 With the Biden administration all but embracing the ludicrous benchmarks of the “Green New Deal,” it’s...
CASE Op-Ed – Las Cruces Sun-News: Fracking in New Mexico Helps Create Jobs
Matthew Kandrach – President, CARE January 8, 2020 New Mexico is a testament to the economic power of horizontal drilling,...
CASE Op-Ed – RealClear Energy: Costly Electric Vehicles Kill Economic Growth and Won’t Save the Planet
Gerard Scimeca – Chairman, CASE July 16, 2019 https://bit.ly/2JB88Fc In an era when electric vehicles (EVs) are shaking up...
CASE Op-Ed: Sue Here, Sue Now – How the Left’s Deranged Climate Change Lawsuits Will Make Us All Pay
Gerard Scimeca – Chairman, CASE February 27 – http://bit.ly/2HMTNT4 In case you didn’t get the memo, please be advised that you,...
There They Go Again, Liberal Cities Targeting Energy Companies with Lawsuits
In a bid both to infuse their failing cities with easy cash while playing to their far-left base, another city...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/